PAULINE SAEDLER: Open Payments
NPI 1649259912 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,583 in 110 payments from 15 companies in 2025. Trend: 2023 $1,684 · 2024 $2,232 · 2025 $2,583
Food & beverage: $2,583
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $424 |
| GENZYME CORPORATION | 11 | $420 |
| Novartis Pharmaceuticals Corporation | 23 | $398 |
| ABBVIE INC. | 25 | $366 |
| Incyte Corporation | 11 | $262 |
| UCB, Inc. | 6 | $210 |
| Janssen Biotech, Inc. | 13 | $178 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $90 |
| Lilly USA, LLC | 3 | $72 |
| Organon LLC | 4 | $37 |
Products named: NEMLUVIO, DUPIXENT, COSENTYX, OPZELURA, RINVOQ, Bimzelx, TREMFYA, SKYRIZI.
Industry payments across CA — which companies pay providers there.
